Kennedy Ferruggia, Assistant Editor

Panelists identify key public policies that pharmacies would benefit from acting on in 2024.

Daily multivitamin users were associated with a 4% higher mortality risk compared to nonusers.

The drug is intended to treat individuals with metastatic or locally advanced melanoma.

Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).

The ACIP recommendations are designed to improve access to RSV vaccination, emphasizing the need to get vaccinated.

The designation was approved based on interim data from a phase 1 study that assessed SV-102 among males with metastatic castrate-resistant prostate cancer (mCRPC).

Heath Mart, part of McKesson, offers an online resource to locate resources near independent pharmacies.

Pharmacies can position themselves as leaders in immunization services.

The recent approval could further the use of mRNA technology across other indications.

Shahida Choudhry, PharmD, shares her journey in pharmacy ownership.

Adding a community health worker can improve the overall health equity for your patients.

Pharmacy Times will be at McKesson ideaShare 2024 Conference in New Orleans, Louisiana from June 23 to June 26, 2024.

Ambient-UVB radiation could improve 25(OH)D prediction in the future, improving widespread vitamin D deficiencies among non-White individuals.

Durvalumab plus carboplatin and paclitaxel, continued with durvalumab monotherapy, decreased the risk of disease progression or death by 58%.

Data show that among individuals 60 years and older, the estimated rate of Guillain-Barré syndrome (GBS) after receiving an RSV vaccine was 5.0 and 1.5 per million doses of Abrysvo and Arexvy, respectively.

Donanemab was able to significantly slow clinical progression of Alzheimer disease and amyloid and tau pathology at 76 weeks of treatment.

A single dose of the vaccine showed long-lasting protection against RSV-associated lower respiratory tract disease in older adults.

Endocrine Society Guidelines suggest adults 75 years and older should take the recommended daily dose of vitamin D and are unlikely to benefit from more.

The study compares the safety and efficacy of mRNA-1345 compared to placebo.

Tools provide a safer testing option without using the viral proteins that cause infection.

Individuals from a lower socioeconomic group showed more benefits from low-dose CT screening relating to lung cancer survival.

If approved, zanidatamab will be the first HER2-targeted treatment indicated for individuals with this type of biliary tract cancer.

Researchers aimed to explore impacts of omega-3 fatty acids on children’s behavior, mood, and sleep.

The role of semaglutide as a glucagon-like peptide-1 (GLP-1) receptor antagonist could offer further treatment options to improve patient outcomes.

The results showed that during a 1-month hospital stay, 13% of individuals who experienced RSV-associated acute respiratory failure died.

The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.

The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.

Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.

Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.

Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.